A significant discovery in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This crucial tumor suppressor protein is frequently disabled in several forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research